134 related articles for article (PubMed ID: 6441190)
1. 6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes.
Kuhl P; Shiloh R; Jha H; Murawski U; Zilliken F
Prostaglandins; 1984 Dec; 28(6):783-804. PubMed ID: 6441190
[TBL] [Abstract][Full Text] [Related]
2. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
3. L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor.
Belanger P; Maycock A; Guindon Y; Bach T; Dollob AL; Dufresne C; Ford-Hutchinson AW; Gale PH; Hopple S; Lau CK
Can J Physiol Pharmacol; 1987 Dec; 65(12):2441-8. PubMed ID: 2835137
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).
Sun FF; McGuire JC
Prostaglandins; 1983 Aug; 26(2):211-21. PubMed ID: 6417727
[TBL] [Abstract][Full Text] [Related]
5. The effect of methylmercuric chloride on arachidonic acid metabolism by platelet lipoxygenase.
Ally AI; Miller DR
Prostaglandins Leukot Med; 1984 Aug; 15(2):209-21. PubMed ID: 6436830
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet arachidonic acid 12-lipoxygenase by acetylenic acid compounds.
Sun FF; McGuire JC; Morton DR; Pike JE; Sprecher H; Kunau WH
Prostaglandins; 1981 Feb; 21(2):333-43. PubMed ID: 6784192
[TBL] [Abstract][Full Text] [Related]
7. Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase.
Siegel MI; McConnell RT; Abrahams SL; Porter NA; Cuatrecasas P
Biochem Biophys Res Commun; 1979 Aug; 89(4):1273-80. PubMed ID: 115466
[No Abstract] [Full Text] [Related]
8. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
[TBL] [Abstract][Full Text] [Related]
9. Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate.
Juránek I; Suzuki H; Yamamoto S
Biochim Biophys Acta; 1999 Jan; 1436(3):509-18. PubMed ID: 9989280
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of platelet lipoxygenase by esculetin.
Sekiya K; Okuda H; Arichi S
Biochim Biophys Acta; 1982 Oct; 713(1):68-72. PubMed ID: 6814494
[TBL] [Abstract][Full Text] [Related]
11. Simple single-step high-performance liquid chromatographic method for the separation of cyclooxygenase and lipoxygenase enzyme metabolites of arachidonic acid.
Cockrell CS; Ellis EF
J Chromatogr; 1984 Jun; 308():316-21. PubMed ID: 6430943
[No Abstract] [Full Text] [Related]
12. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins.
Kimura Y; Okuda H; Arichi S; Baba K; Kozawa M
Biochim Biophys Acta; 1985 Apr; 834(2):224-9. PubMed ID: 3922420
[TBL] [Abstract][Full Text] [Related]
13. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
Takayama H; Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
Prostaglandins Leukot Med; 1983 Nov; 12(3):261-72. PubMed ID: 6318227
[TBL] [Abstract][Full Text] [Related]
14. Isolation of glucose-sensitive platelet lipoxygenase products from arachidonic acid.
Bryant RW; Bailey JM
Adv Prostaglandin Thromboxane Res; 1980; 6():95-9. PubMed ID: 6770609
[No Abstract] [Full Text] [Related]
15. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
Hidaka T; Takeo K; Hosoe K; Katsumi I; Yamashita T; Watanabe K
Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
[TBL] [Abstract][Full Text] [Related]
16. Purification and properties of arachidonate-15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes.
Narumiya S; Salmon JA; Flower RJ; Vane JR
Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():77-82. PubMed ID: 6211962
[No Abstract] [Full Text] [Related]
17. Metabolism of 4,7,10,13,16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase.
Milks MM; Sprecher H
Biochim Biophys Acta; 1985 Jun; 835(1):29-35. PubMed ID: 3924108
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of the prostaglandin/thromboxane synthetase of human blood platelets and comparison with the synthetase of bovine seminal vesicles.
White HL; Glassman AT
Prostaglandins; 1976 Nov; 12(5):811-28. PubMed ID: 10602
[TBL] [Abstract][Full Text] [Related]
19. Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Bedord CJ; Young JM; Wagner BM
J Invest Dermatol; 1983 Dec; 81(6):566-71. PubMed ID: 6417248
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of maesanin and analogs on arachidonic acid metabolizing enzymes.
Abourashed EA; Muhammad I; Resch M; Bauer R; el-Feraly FS; Hufford CD
Planta Med; 2001 Jun; 67(4):360-1. PubMed ID: 11458456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]